(CNM).
METHODS
Patients. Serum was obtained from four patients who had plasma cell dyscrasia and peripheral neuropathy and whose IgM paraproteins reacted with human PNM in the complement-fixation and immunoabsorption assays (9, 10) . For controls we used serum from six patients who had neuropathy but whose IgM paraproteins did not react with human PNM in the complement-fixation or immunoabsorption assay, from four patients with IgM paraproteins but no neuropathy, and from three normal subjects.
Preparation of Membranes and Polyacrylamide Gel Electrophoresis. Human brain white matter and sciatic and femoral nerves were obtained at autopsy (12-18 hr after death) from patients who had no neurological disease, and CNM and PNM were isolated by sucrose density ultracentrifugation (11, 12) . Three different PNM and CNM preparations were used. PNM was also prepared from baboon or rabbit nerve, and membranes were prepared from T cells isolated from a patient with T-cell leukemia and from cultured human myotubes and fibroblasts from normal individuals (provided by Armond Miranda). The membrane fractions were prepared by sonication, centrifugation at 1000 X g for 10 min, and centrifugation at 100,000 X g for 1 hr to pellet the membranes. The myelin and other membrane fractions were Iyophilized and delipidated by three washes in cold ether ethanol, 3:2 (vol/vol). The proteins were solubilized in sample buffer and separated by electrophoresis in 12% polyacrylamide slab gels with a 6% stacking gel in sodium dodecyl sulfate (13) .
Immunoenzymatic Identification ofthe Antigens. After electrophoresis the proteins were transferred onto nitrocellulose sheets (Schleicher & Schuell) and the antigens that reacted with the paraproteins were identified by an immunoenzymatic technique (14) . The nitrocellulose blots were incubated with 3% bovine serum albumin to saturate the remaining protein binding sites, treated with serum from a patient or control, washed, and treated with peroxidase-conjugated rabbit anti-human IgM (aIgM-P), peroxidase-conjugated anti-human IgG (aIgG-P), or peroxidase-conjugated anti-human K (aK-P) or A (aA-P) light chains, at a dilution of 1:500 (Dako, Accurate Chemical, New York). The immune reactions were visualized with 0.1% 3,3'-diaminobenzidine tetrahydrochloride (Sigma)/0. 1% imidazole/ 0.1% hydrogen peroxide.
Serum was screened for the presence of IgM reactive with human CNM or PNM proteins by incubating the nitrocellulose blots with serum at a dilution of 1:200, followed by aIgM-P as the second antibody. Reactive serum was also examined by using aIgG-P, aK-P, or aA-P as the second antibody. Reactive sera from two patients were absorbed with human PNM by incubating 0.1 ml of 1:10 dilution of serum with 1 mg of lyophilized PNM overnight, five times, and the absorbed sera then were used to immunostain PNM and CNM. Control sera were absorbed with equal amounts of rat liver powder. The nitrocellulose blots were also immunostained with rabbit antiserum to mouse myelin basic protein or rabbit antiserum to cerebroAbbreviations: PNM, peripheral nerve myelin; CNM central nervous system myelin; aIgM-P, peroxidase-conjugated rabbit anti-human IgM; aIgG-P, peroxidase-conjugated rabbit anti-human IgG; aK-P, peroxidase-conjugated anti-human K light chains; aA-P, peroxidaseconjugated rabbit anti-human A light chains.
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To determine whether the patients' sera contained IgG antibodies directed at the same myelin antigens, immunostaining was performed with aIgG-P as the second antibody. Immunostaining of PNM was impossible to interpret because incubation with aIgG-P alone yielded multiple bands (Fig. 3D) possibly because of adsorption of IgG to PNM during homogenization (17, 18) or because ofcross-reactive antigens in PNM. However, aIgG-P did not react with CNM, and immunostaining CNM with the patients' sera and aIgG-P revealed no reaction in three of the patients (Fig. 3B) . In one of these four patients, immunostaining with aIgG-P was identical to that seen with aIgM-P (Fig. 3C) (Fig. 4) . Immunostaining ofbaboon myelin, however, was identical to that of human myelin.
DISCUSSION
In the four patients with neuropathy and anti-PNM IgM paraproteins, the IgM antibodies reacted with a protein of approximately 100,000 daltons in human PNM and with one or more proteins of similar molecular weight in human CNM. The multiple closely spaced bands in the CNM were seen with three different CNM preparations and probably resulted from postmortem autolysis ofa single protein because a single dense band was frequently seen and because absorption with human PNM eliminated the immunostaining of all the CNM bands. The identified antigens are significantly larger than the major myelin proteins but are similar in size to myelin-associated glycoprotein (19) . The antigen may be species restricted because it is found in human and baboon PNM but not in rabbit PNM by a number of assays including complement fixation, immunoabsorption, and immunostaining of myelin proteins (9, 10) .
We therefore refer to these proteins as the CNM or PNM "neuropathy associated proteins" (NAP). (24) (25) (26) , but none of these has been shown to be immunologically involved in humans (27) . It is unlikely that the paraproteins share antigenic specificity with anticerebroside antibodies because there was no immunostaining of neuropathy-associated proteins by anticerebroside antiserum and because the paraproteins did not react with rabbit PNM or with chloroform/methanol-treated human PNM (9, 10) which contain cerebrosides. Perhaps only a few myelin constituents can induce autoimmunity in humans, and the proteins we identified may be involved in other autoimmune demyelinating diseases of the peripheral or central nervous system. The normal role of these proteins remains to be elucidated.
